US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.620
  • +0.140+3.13%
Close Apr 26 16:00 ET
  • 4.520
  • -0.100-2.17%
Post 17:46 ET
265.82MMarket Cap115.50P/E (TTM)

Vanda Pharmaceuticals Key Stats

Vanda Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 7, 2024

Revenue(YoY)

45.27M

-29.79%
EPS(YoY)

-0.04

-133.33%

No Data

Vanda Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 3, 20232023/Q1-- / 62.500M--
Feb 7, 20242023/Q445.271M / 37.000M--
Nov 8, 20232023/Q338.815M / 44.500M--
Jul 27, 20232023/Q246.056M / 49.000M--
Feb 8, 20232022/Q464.482M / 67.600M--
Nov 2, 20222022/Q365.318M / 71.000M--
Aug 3, 20222022/Q264.390M / 67.000M--
May 5, 20222022/Q160.192M / 58.000M--
Feb 23, 20222021/Q468.019M / 70.038M--
Nov 3, 20212021/Q370.095M / 74.250M--
DatePeriodRevenue/EstimateEarnings Call
May 3, 20232023/Q1-- / 62.500M--
Feb 7, 20242023/Q445.271M / 37.000M--
Nov 8, 20232023/Q338.815M / 44.500M--
Jul 27, 20232023/Q246.056M / 49.000M--
Feb 8, 20232022/Q464.482M / 67.600M--
Nov 2, 20222022/Q365.318M / 71.000M--
Aug 3, 20222022/Q264.390M / 67.000M--
May 5, 20222022/Q160.192M / 58.000M--
Feb 23, 20222021/Q468.019M / 70.038M--
Nov 3, 20212021/Q370.095M / 74.250M--

Unlock Free Earnings Estimates

Vanda Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg